Precision HealthCare Consultants is a global healthcare advisory and clinical research support partner to pharmaceutical, biotechnology, medical device companies, and CROs operating across the United States, Africa, Asia, with active expansion underway across the Middle East and other emerging global markets.
Our work is grounded in the principles outlined by the U.S. Food and Drug Administration and the International Council for Harmonisation—supporting clinical trials that are inclusive, representative, ethical, and reflective of real-world patient populations.
We help life sciences organizations translate global trial equity guidance into practical, compliant, and executable solutions, particularly in regions and communities that have historically been underrepresented in clinical research.
Precision specializes in pilot-based engagements that allow sponsors and CROs to operationalize inclusive trial strategies before scaling globally.
Our pilots support:
Each pilot is time-bound, milestone-driven, and outcomes-focused, enabling organizations to validate approaches while maintaining regulatory rigor.
Precision works as a trusted extension of CRO and sponsor teams, strengthening trial delivery while reinforcing compliance with ICH E6 (GCP) and evolving global regulatory expectations.
We provide CRO-aligned support across:
Our teams integrate seamlessly into existing trial infrastructures—supporting delivery across diverse geographies without adding complexity.
Global trial guidance consistently emphasizes that equity requires early, sustained, and ethical engagement—especially in communities where trust, access, and awareness have been limited.
Precision specializes in engaging forgotten communities across:
We partner with clinics, community organizations, patient advocates, and local leaders to support culturally responsive outreach, ethical participation, and sustained engagement—driving stronger enrollment, improved retention, and more representative data.
Precision operates across 39 U.S. states, multiple countries in Africa and Asia, and three continents, with continued expansion into the Middle East and emerging global markets.
We help sponsors and CROs:
Our model ensures trials are both globally compliant and locally credible.
Who We Support
Pharma • Biotech • Medical Device • CROs • Research Sponsors
What We Deliver
Clinical trial support • Inclusive patient recruitment • Community engagement • CRO enablement • Data & documentation support
Where We Operate
United States • Africa • Asia • Expanding across the Middle East & emerging markets
How We Engage
Pilot-based • Compliant • Outcomes-driven
Je, makampuni ya dawa hufikia vipi watu ambao hawajahudumiwa wakati watu hao hawaamini maduka makubwa ya dawa? Tunajua jambo moja au mawili kuhusu hilo. Wakati CDC inahitaji huduma kuhamasishwa wakati wa janga, vipi kuhusu kuweka buti ardhini kutoka Asia hadi Afrika? Wataalam walio na nyenzo zinazofaa za kitamaduni, ufikiaji mzuri, huanza na uelewa. Wakati magonjwa ya zinaa yanapoongezeka, vipi kuhusu kufikia zaidi ya maeneo ya kliniki ya chuo kikuu ili kupata wagonjwa ambao ni sugu kwa matibabu ya kawaida? Ubunifu katika dawa unamaanisha kutafuta suluhu mahali zinapohitajika zaidi. Chuo kikuu kinapouliza kutambua maeneo mwafaka ya kliniki na majangwa ya huduma ya afya, vipi kuhusu kupeleka timu zinazozungumza lugha za asili? Timu zinazojua tofauti kati ya jumuiya hizi kwa sababu wao ni sehemu ya jumuiya hizi. Unaweza usiwe na ufikiaji huo, lakini tunayo. Hizi ni hadithi za baadhi ya mafanikio yetu wenyewe. Hatuuite mkakati tu, tunauita ubinadamu. Jamii zinatuamini kwa sababu sisi si watu wa nje. Tunaishi na kufanya kazi kati yao. Tunaunda uhusiano, sio shughuli. Kumbuka, wale ambao ni wageni kwa wengine ni majirani kwa wengine. Idadi ya watu inapoonekana kutoweza kufikiwa, shirikiana na timu ambayo tayari ipo.
Whether launching a new study, recovering enrollment, expanding into Africa, Asia, or the Middle East, or strengthening global trial equity strategies, Precision helps life sciences organizations move from guidance to execution—responsibly, compliantly, and with impact.
